| scholarly article | Q13442814 |
| P50 | author | Mark O'Driscoll | Q55149611 |
| Gareth J. Morgan | Q61996585 | ||
| P2093 | author name string | A Jack | |
| P A Jeggo | |||
| S Rollinson | |||
| P L Roddam | |||
| P2860 | cites work | Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells | Q42667161 |
| Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity | Q42944177 | ||
| Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. | Q46031860 | ||
| DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains | Q46835609 | ||
| V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma | Q47834210 | ||
| Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. | Q52863563 | ||
| V(D)J Recombination in Mature B Cells: A Mechanism for Altering Antibody Responses | Q56687402 | ||
| New guardians of the genome | Q59000055 | ||
| DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes | Q22007974 | ||
| DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity | Q24534080 | ||
| Crystal structure of the Xrcc4 DNA repair protein and implications for end joining | Q24597643 | ||
| The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations | Q24685574 | ||
| Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase | Q28138342 | ||
| DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation | Q28141630 | ||
| The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997 | Q28143029 | ||
| Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development | Q28143170 | ||
| Chromosomal stability and the DNA double-stranded break connection | Q28205315 | ||
| Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV | Q28504490 | ||
| Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity | Q28506163 | ||
| Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development | Q28512255 | ||
| How to make ends meet in V(D)J recombination | Q32067274 | ||
| Somatic hypermutation of immunoglobulin and non-immunoglobulin genes | Q33770250 | ||
| Regulated genomic instability and neoplasia in the lymphoid lineage | Q33789653 | ||
| Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4. | Q33853314 | ||
| Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient | Q33867168 | ||
| Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. | Q33952028 | ||
| Immunodeficiency associated with DNA repair defects | Q33962066 | ||
| DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency | Q34108148 | ||
| Linking class-switch recombination with somatic hypermutation | Q34297090 | ||
| Mechanisms of chromosomal translocations in B cell lymphomas | Q34405423 | ||
| Molecular mechanisms of DNA double strand break repair | Q34484541 | ||
| Ku70 is required for late B cell development and immunoglobulin heavy chain class switching | Q36401127 | ||
| Molecular and biochemical characterization of xrs mutants defective in Ku80. | Q40021061 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple myeloma | Q467635 |
| P304 | page(s) | 900-905 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Journal of Medical Genetics | Q14640281 |
| P1476 | title | Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination | |
| P478 | volume | 39 |
| Q34347694 | A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. |
| Q37857869 | Abnormalities of DNA repair mechanisms in common hematological malignancies |
| Q34343834 | Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms |
| Q33807557 | Assessing Candidate Gene nsSNPs for Phenotypic Differences in Double-Strand Break Repair Using Radiation-Induced gammaH2A.X Foci |
| Q49384931 | Association of DNA repair gene polymorphisms with genotoxic stress in underground coal miners. |
| Q54378893 | Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population. |
| Q28388312 | DNA damage response genes and the development of cancer metastasis |
| Q37135926 | DNA double strand break repair via non-homologous end-joining |
| Q37068167 | DNA repair gene polymorphisms and risk of pancreatic cancer |
| Q37505517 | DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment |
| Q80342487 | Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics |
| Q36790428 | Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation |
| Q47747812 | Genetic intersection of male infertility and cancer |
| Q37016852 | Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions |
| Q92491547 | Genetic predisposition for multiple myeloma |
| Q21145035 | Genetic variation in an individual human exome |
| Q37924891 | Genetic variations in multiple myeloma I: effect on risk of multiple myeloma |
| Q39913010 | Impaired NHEJ function in multiple myeloma |
| Q38163845 | Inherited genetic susceptibility to multiple myeloma |
| Q37778044 | Ligase IV Syndrome |
| Q47901808 | Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study |
| Q24296672 | Phosphorylation and regulation of DNA ligase IV stability by DNA-dependent protein kinase |
| Q80413350 | Polymorphisms in the DNA ligase IV gene might influence the risk of acute lymphoblastic leukemia in children |
| Q46828004 | Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma |
| Q33897620 | Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival |
| Q37713997 | Primary immunodeficiencies associated with DNA-repair disorders |
| Q34340919 | Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis |
| Q35849056 | Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes |
| Q37628194 | Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation |
| Q35608847 | Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure |
| Q38690281 | The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer |
| Q36231119 | The repair of DNA damages/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models. |
| Q35170919 | The role of DNA breaks in genomic instability and tumorigenesis |
| Q35830410 | The role of the non-homologous end-joining pathway in lymphocyte development |
| Q38196597 | The spatial organization of non-homologous end joining: from bridging to end joining |
| Q36252762 | Tumor suppressor genetics |
| Q42540883 | Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders |
Search more.